main content start
¿Le gustó este contenido?
Myelodysplastic Syndromes 3m 18s

Anemia of MDS

Publicado04 Oct 2022
Anemia is common feature of MDS with 90% patients having anemia at diagnosis or initial presentation. Anemia not only impacts quality of life but is also prognostic in nature.
Transfusion dependent MDS patients have worse prognosis compared to transfusion independent patients. Iron overload associated with transfusion dependence contributes to worse prognosis. Low risk patients are often treated with Erythropoietin, Luspatercept can considered for patients with ring sideroblasts while high risk patients are treated with Hypomethylating agents. Lenalidomide is particularly useful for patients with Del 5-q abnormality.
anemia mds transfusion dependence

Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.

Ventajas de registrarse en MedEnrich
Contenido en línea en varios formatos
Contenido personalizado
Acceso ilimitado a todas las funciones
Hi, can I help?
Chat de ayudaX
Equipo de soporte
¡Hola! ¿Cómo puedo ayudarlo/a hoy?
Por favor seleccione alguna de las siguientes opciones.

Buscar información

Problemas con el inicio de sesión o registro

Compartir un comentario